-- Global Biomarker Market to reach USD XX billion by 2025. Global Biomarker Market valued approximately USD 29.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2018-2025. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries are the substantial driving factors of the market across the world.
Request a Sample of The Report: http://www.arcognizance.com/enquiry-sample/289247
Furthermore, growing demand from emerging economies is creating numerous opportunity in the market over the upcoming years. Biomarkers are used to assist medical professionals to take effective clinical decisions and it also helps in diagnosing the health of patients. Also, biomarkers are predicting drug efficacy quickly than conventional clinical endpoints. These benefits of Biomarker also increasing demand among its end-user industries over the upcoming years. However, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage is the restraining factors of the market across the globe.
The regional analysis of Global Biomarker Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region in the global Biomarker market due to growing prevalence of cancer and increasing adoption of precision medicine in the region. Europe is also estimated to grow in the global Biomarker market over the forecasted period 2018-2025. However, Asia-Pacific is also witnessed to grow at higher rate over the forecasted period 2018-2025.
The major market player included in this report are:
Abbott Laboratories
Medtronic
BG Medicine Inc.
Hoffmann LA Roche Ltd.
Siemens Healthnineers
Nexus-DX
Qiagen N.V.
Lifesign LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Indication:
Cancer, Cardiovascular Disorder
Infectious Diseases
Neurological Disorder
Immunological Disorder
Others
By Application:
Diagnosis
Drug Discovery and Development
Others
By End-Use:
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
By Product Type:
Biomarker Test Kits
Biomarker Analyzers
Buy the Report@http://www.arcognizance.com/purchase/289247
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
Target Audience of the Global Biomarker Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Browse The report: http://www.arcognizance.com/report/global-biomarker-market-size-study-by-disease-indication-cancer-cardiovascular-disorder-infectious-diseases-neurological-disorder-immunological-disorder-others-by-application-by-end-use-by-product-type-and-regional-forecasts-2018-2025
Major Points From the Table of Content:
Executive Summary
Biomarker Market Definition and Scope
Biomarker Market Dynamics
Biomarker Market Industry Analysis
Biomarker Market, by Disease Indication
Biomarker Market, by Application
Biomarker Market, by End-Use
Biomarker Market, by Product Type
Biomarker Market, by Regional Analysis
Competitive Intelligence
Research Process
About Us:
Analytical Research Cognizance is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics" based on the data collection facilities of big data, the face of "business research facilities" has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the "out of the box" developments in the market.
Contact Info:
Name: Matt Wilson
Email: Send Email
Organization: Analytical Research Cognizance
Address: 100 Church street, 8th floor, Manhattan, New york, 10007
Phone: +1 (646) 434-7969
Website: http://www.arcognizance.com/report/global-biomarker-market-size-study-by-disease-indication-cancer-cardiovascular-disorder-infectious-diseases-neurological-disorder-immunological-disorder-others-by-application-by-end-use-by-product-type-and-regional-forecasts-2018-2025
Release ID: 494203
Google
RSS